These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. Lee DM, Knight-Gibson C, Samuelsson O, Attman PO, Wang CS, Alaupovic P. Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103 [Abstract] [Full Text] [Related]
5. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Salmon P. Metabolism; 1980 Jul; 29(7):654-61. PubMed ID: 7382829 [No Abstract] [Full Text] [Related]
6. Lipids and lipoproteins in chronic alcohol abuse. Masarei JR, Fung WP, Prindiville LP, Puddey IB. Ann Acad Med Singap; 1982 Oct; 11(4):601-7. PubMed ID: 6962684 [No Abstract] [Full Text] [Related]
7. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease. Samuelsson O, Attman PO, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P. Nephron; 1997 Oct; 75(3):286-94. PubMed ID: 9069450 [Abstract] [Full Text] [Related]
8. Short- and long-term effects of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins of obese subjects. Bosello O, Cominacini L, Zocca I, Garbin U, Compri R, Davoli A, Brunetti L. Ann Nutr Metab; 1988 Oct; 32(4):206-14. PubMed ID: 3143302 [Abstract] [Full Text] [Related]
9. The pattern of major serum apolipoproteins during the early neonatal period. Stozický F, Slabý P, Voleniková L. Acta Paediatr Scand; 1982 Mar; 71(2):239-41. PubMed ID: 6814172 [Abstract] [Full Text] [Related]
11. Changes with aging in serum lipoproteins and apolipoprotein C subclasses. Takeuchi N, Matsumoto A, Katayama Y, Arao M, Koga M, Nakao H, Uchida K. Arch Gerontol Geriatr; 1983 Jul; 2(1-2):41-8. PubMed ID: 6578706 [Abstract] [Full Text] [Related]
13. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia. Saku K, Sasaki J, Arakawa K. Clin Ther; 1989 Jul; 11(3):331-40. PubMed ID: 2743372 [Abstract] [Full Text] [Related]
14. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Attman PO, Alaupovic P. Nephron; 1991 Jul; 57(4):401-10. PubMed ID: 2046821 [Abstract] [Full Text] [Related]
15. [Value of the analysis of lipoproteins after myocardial infarction]. Dewailly P, Mellin D, Moulin S, Rouget JP, Sezille G, Jaillard J. Presse Med; 1991 Jul; 12(29):1807-10. PubMed ID: 6224195 [Abstract] [Full Text] [Related]
16. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Lopes-Virella MF, Wohltmann HJ, Mayfield RK, Loadholt CB, Colwell JA. Diabetes; 1983 Jan; 32(1):20-5. PubMed ID: 6336700 [No Abstract] [Full Text] [Related]
17. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life. van Biervliet JP, Rosseneu M, Bury J, Caster H, Stul MS, Lamote R. Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061 [Abstract] [Full Text] [Related]
18. Human apolipoprotein C-I: concentration in blood serum and lipoproteins. Polz E, Kotite L, Havel RJ, Kane JP, Sata T. Biochem Med; 1980 Dec; 24(3):229-37. PubMed ID: 7283981 [No Abstract] [Full Text] [Related]